NCT06070012 2026-02-27Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal MelanomaUniversity of PittsburghPhase 2 Recruiting44 enrolled
NCT07276386 2025-12-11Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Recruiting18 enrolled